MAPT and Alzheimer disease: In conclusion, we highlight (1) regions on tau and aSyn in the human brain that are available for antibody binding under non-denaturing conditions (2) distinct tau and aSyn molecular profiles for pure and mixed cases and (3) tau/aSyn co-aggregates in astrocytes of AD-LB cases within the MTG (Fig. 10).